CKS-12628-07761
2 vaccinations
5 coded responses
25 check-ins
5 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 554 / MN
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Pfizer-BioNTech
- 2021-02-24
- 2021-02-25
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-10
-
2021-03-17
Dose 2 — Pfizer-BioNTech
- 2021-03-17
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-11
Survey response — day 21, dose 2MedDRA: Dizziness, Joint swelling, Peripheral swelling — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Dizziness, lightheaded, swelling of feet, ankles, and handsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Survey response — day 28, dose 2MedDRA: Dizziness, Localised oedema — Feeling: GoodFree text: Swelling feet, legs, ankles, and occasionally hands (edema). Occasional dizziness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
- 2021-04-28
-
2021-06-16
Survey response — 3 months, dose 2MedDRA: Brain fog, Condition aggravated, Disability, Disturbance in attention, Dizziness, Fatigue, Headache, Heart rate increased, Mental impairment, Nausea, Tremor — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Dizziness, nausea, headaches, extreme fatigue, complete exhaustion, shakiness, rapid heartbeat, increasing/progressive disability, brain fog, inability to think clearlyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-16
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-24
-
2021-09-15
Survey response — 6 months, dose 2MedDRA: Asthenia, Chronic fatigue syndrome, Coordination abnormal, Fatigue, Gait disturbance, Malaise, Post-acute COVID-19 syndrome — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Long COVID, Post Viral Fatigue Syndrome, Post Exertional Malaise, discoordination in legs, trouble walking, extreme fatigue and weaknessMedDRA releases: 2024-11 · check-in free text available
-
2021-09-15
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-16
-
2021-09-16
Call successfulParticipant prefers to complete VAERS report online
-
2022-03-17
Survey response — 12 months, dose 2MedDRA: Ataxia, Brain fog, Chronic fatigue syndrome, Cognitive disorder, Malaise, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Post Viral Fatigue Syndrome, Post Exertional Malaise, Gait Ataxia, brain fog/cognitive issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-03-17
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Pfizer-BioNTech | |
| 2 | 2021-03-17 | Pfizer-BioNTech |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 7 — day 21, dose 2
Symptoms: Dizziness, lightheaded, swelling of feet, ankles, and hands
Release 7 — day 28, dose 2
Symptoms: Swelling feet, legs, ankles, and occasionally hands (edema). Occasional dizziness.
Release 9 — 3 months, dose 2
Symptoms: Dizziness, nausea, headaches, extreme fatigue, complete exhaustion, shakiness, rapid heartbeat, increasing/progressive disability, brain fog, inability to think clearly
Release 9 — 6 months, dose 2
Symptoms: Long COVID, Post Viral Fatigue Syndrome, Post Exertional Malaise, discoordination in legs, trouble walking, extreme fatigue and weakness
Release 11 — 12 months, dose 2
Symptoms: Post Viral Fatigue Syndrome, Post Exertional Malaise, Gait Ataxia, brain fog/cognitive issues
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Ataxia | · | · | ✓ |
| SD | Brain fog | ✓ | ✓ | ✓ |
| SD | Chronic fatigue syndrome | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ○ |
| SD | Coordination abnormal | · | · | ✓ |
| SD | Disability | · | · | ✓ |
| SD | Disturbance in attention | ✓ | ✓ | ○ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gait disturbance | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Joint swelling | ✓ | ✓ | ✓ |
| SD | Localised oedema | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Mental impairment | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Tremor | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release